Review Article
Niosome as an Effective Nanoscale Solution for the Treatment of Microbial Infections
Table 2
Examples of surfactants used in niosome nanocarriers.
| Class of nonionic surfactant | Name of nonionic surfactant | Combined agent | Application of synthesized niosome | Ref. |
| Sorbitan fatty acid esters | Span 80 | Clarithromycin | As a niosomal carrier with sustained and controlled release to increase drug bioavailability | [91] | Span 60 | Melittin | As a niosomal system to inhibit the bacterial skin infection | [92] | Span 40 | Imipenem | As a functional nanocarrier to prevent biofilm formation and reduce the antibiotic resistance of methicillin-resistant S. epidermidis | [93] | Span 20 | Lomefloxacin | As a niosome carrier to increase the bioavailability and antibacterial effects of lomefloxacin against ocular infections | [94] | Polyoxyethylene sorbitan fatty acid esters | Tween 80 | Moxifloxacin | As an efficient nanocarrier for controlled delivery of antimicrobial agents against P. aeruginosa | [29] | Tween 60 | Azithromycin | As a niosomal system to improve bacterial conjunctivitis infection and targeted delivery of azithromycin | [32] | Tween 40 | Vancomycin | As a niosomal formulation to inhibit the biofilm formation and staphylococcal colonization on abiotic/nonbiological surfaces | [95] | Tween 20 | Hydrophilic silver nanoparticles (AgNPs) | As a niosome system with stable properties for efficient delivery of AgNPs, drugs, and biomolecules | [96] | Alkyl ethers | Brij 72, 78, & 92 | Carvedilol | As a carrier in the form of proniosomal gel to increase the skin penetration of carvedilol | [97] | Brij 52 | Brimonidine tartrate | As an ocular drug delivery system in the form of a proniosomal gel to promote bioavailability and sustained release of brimonidine tartrate | [98] |
|
|